Report ID: SQMIG35J2043
Report ID:
SQMIG35J2043 |
Region:
Global |
Published Date: February, 2024
Pages:
224
|
Tables:
92 |
Figures:
76
North America is expected to account for the lion's share of the global human microbiome market. The region's domination is due to the rising prevalence of lifestyle problems and advances in next-generation sequencing. For example, Illumina Inc., a major player in the United States, claims that the introduction of next-generation sequencing enables various high-profile joint projects, like the Human Microbiome Project and MetaHIT. Using Next Generation Sequencing as a basic tool, these projects have published a wide range of data on the human microbiome.
Europe is likely to increase its market share during the forecast period as a result of extensive research and development of novel human microbiome applications. According to NCBI, new microbiome programmes such as ONCOBIOME, MICROB-predict, and GEMMA are focused on oncology, mapping of human microbiota, and autistic spectrum disorders, respectively, and are expected to boost market expansion in this region in March 2020.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35J2043